Understanding the cellular properties controlling neural stem and progenitor cell (NSPC) fate choice will improve their therapeutic potential. The electrophysiological measure whole-cell membrane capacitance reflects fate bias in the neural lineage but the cellular properties underlying membrane capacitance are poorly understood. We tested the hypothesis that cell surface carbohydrates contribute to NSPC membrane capacitance and fate. We found NSPCs differing in fate potential express distinct patterns of glycosylation enzymes. Screening several glycosylation pathways revealed that the one forming highly branched N-glycans differs between neurogenic and astrogenic populations of cells in vitro and in vivo. Enhancing highly branched N-glycans on NSPCs significantly increases membrane capacitance and leads to the generation of more astrocytes at the expense of neurons with no effect on cell size, viability, or proliferation. These data identify the N-glycan branching pathway as a significant regulator of membrane capacitance and fate choice in the neural lineage.
INTRODUCTION
Neural stem cells (NSCs) develop into neurons, astrocytes, and oligodendrocytes and understanding how choices are made among these different fates will improve the use of these cells in transplantation therapies (Cao et al., 2002) . NSCs expanded in vitro for therapeutic purposes generate a heterogeneous population of neural stem and progenitor cells (NSPCs) with varying ratios of progenitors linked to distinct cell fates. The cell biological characteristics that distinguish cells biased toward forming neurons from those that will generate astrocytes are ill-defined and current cell surface markers limited. Understanding the intrinsic properties of neuron-and astrocyte-biased cells and the mechanisms that govern their fate will improve the ability to predict or control the differentiation potential of transplanted cells, enhancing the reproducibility and effectiveness of NSPC therapeutics.
A cell biological characteristic that predicts fate in many stem cell lineages is whole-cell membrane capacitance, an electrophysiological property of the plasma membrane. Whole-cell membrane capacitance can be used to identify and enrich cells at distinct stages of differentiation and is measured for living cells, non-invasively, without labels by dielectrophoresis (DEP) or impedance sensing. Analysis or sorting of NSPCs by DEP is not toxic since the short-term DEP exposure needed for these applications does not alter cell survival, proliferation, or differentiation . Membrane capacitance discriminates between undifferentiated cells and their differentiated progeny. NSPCs are distinguished from differentiated neurons and astrocytes and prospectively sorted from neurons by membrane capacitance using DEP (Flanagan et al., 2008; Prieto et al., 2012) . Membrane capacitance defines and enables the enrichment of undifferentiated and differentiated cells in the hematopoietic stem cell, mesenchymal stem cell (MSC)/adipose-derived stem cell, and embryonic stem cell lineages, indicating the relevance of biophysical properties to fate across multiple stem cell types (for a recent review see Lee et al., 2018) .
For NSCs and MSCs, inherent electrophysiological properties of undifferentiated cells predict their differentiated fate. The neurogenic and astrogenic fate potential of NSPC populations (both human and mouse) are reflected in distinct membrane capacitance values, and membrane capacitance dynamically reflects the declining neurogenic potential of human NSPCs (Labeed et al., 2011) . Importantly, the sufficiency of membrane capacitance as a marker of fate in the neural lineage is shown by the enrichment of neurogenic or astrogenic cells from a mixed population of undifferentiated mouse NSPCs by DEP Simon et al., 2014) . Similarly, the osteogenic fate potential of undifferentiated MSCs is detected by DEP (Hirota and Hakoda, 2011) . Since the biophysical property whole-cell membrane capacitance is linked to fate, determining the components contributing to this measure may reveal novel insights into processes governing cell differentiation.
The cellular and molecular structures influencing membrane capacitance are not well understood. The DEP frequencies used for stem cell analysis are not in the range used to detect resting membrane potential (Gheorghiu, 1993; Flanagan et al., 2008) . Expression of a G proteincoupled receptor in yeast did not alter capacitance (Stoneman et al., 2007) , although expression of channelrhodopsin-2 in HEK293 cells did (Zimmermann et al., 2008) , suggesting the possibility that certain membrane proteins can affect membrane capacitance. Based on biophysical theory, membrane capacitance should be impacted by plasma membrane surface area and thickness. While NSPCs that have distinct membrane capacitance values do not differ in size as measured by phase contrast microscopy (Labeed et al., 2011; Nourse et al., 2014) , they may differ in membrane microdomains not visible at that level of resolution. Cell membrane microdomains such as ruffles or microvilli are expected to alter membrane capacitance by increasing cell surface area (Wang et al., 1994) . Membrane thickness affected by the lipid composition of the plasma membrane has been proposed to influence whole-cell membrane capacitance, although there are constraints on the absolute thickness of the lipid bilayer set by the size of phospholipid head groups and fatty acid tails (Muratore et al., 2012) . Modification of vesicle phospholipid bilayers with polyethylene glycol altered membrane capacitance (Desai et al., 2009) , suggesting that cell surface modifications could contribute to membrane capacitance of cells.
A cellular process that modifies the plasma membrane surface and impacts membrane microdomains is glycosylation, by which carbohydrates able to store charge are added to plasma membrane proteins and lipids. Domains of glycosylated cell surface molecules generate surface undulations to increase surface area (Zhao et al., 2002) , create structures extending up to 200 nm from the cell surface to make ''thickened'' membrane structures (Paszek et al., 2014) , and influence the protein makeup of the plasma membrane (Nabi et al., 2015) . Glycosylation is critical for normal nervous system development (Haltiwanger and Lowe, 2004) , and changes in glycosylation patterns during cortical brain development correlate with developmental periods of increased neuron or astrocyte production (Flaris et al., 1995; Ishii et al., 2007) . Treatment of NSPCs with agents that modify cell surface carbohydrates alters their behavior in DEP , leading to the hypothesis that glycosylation may impact membrane capacitance and the fate of NSPCs.
RESULTS

Neurogenic and Astrogenic NSPCs Exhibit Differences in Glycosylation Enzymes
In the developing cerebral cortex, neurons are formed early (starting in mice at approximately embryonic day 10 [E10]) and neurogenesis decreases as astrocyte generation commences (around E16). Neurons and astrocytes are generated from NSPCs in the developing dorsal telencephalon stem cell niche (the ventricular zone/subventricular zone). In contrast, most cortical oligodendrocytes are generated ventrally in the ganglionic eminence and migrate into the cortex at later developmental stages (He et al., 2001) . To test whether glycosylation patterns vary with fate potential, we isolated NSPCs from embryonic dorsal forebrain at stages when either more neurons (E12) or astrocytes (E16) are formed (Qian et al., 2000) . E12 neuron-biased and E16 astrocyte-biased cells differ in fate-specific membrane capacitance, making these cells reasonable tests for the contribution of glycosylation to this biophysical property (Labeed et al., 2011) .
Glycosylation is controlled by enzymes in the endoplasmic reticulum (ER) and Golgi that sequentially add and remodel sugars (glycans) attached to proteins and lipids destined for expression on the cell surface or extracellular secretion. We compared RNA levels of glycosylation enzymes in E12 and E16 NSPCs and found multiple differentially expressed genes (Tables S1-S3 ). Since membrane capacitance reflects characteristics of the plasma membrane, we prioritized enzymes expected to generate cell surface glycans, so enzymes involved in ER quality control, targeting of enzymes to lysosomes, or lysosomal degradation of glycans were not considered further. We focused on N-glycosylation since virtually all cell surface proteins are N-glycosylated and N-glycosylation controls function of membrane receptors mediating responses to extracellular cues. Loss of N-glycosylation enzymes causes defects in neural development (Schachter, 2001) . N-Glycosylation leads to formation of membrane microdomains affecting cell surface area, which is thought to impact capacitance. Most O-glycosylated proteins are secreted and many become components of the extracellular matrix (ECM), but some, such as the heparan sulfate proteoglycans glypican and syndecan, can be membrane bound. Contributions of O-glycosylation to membrane capacitance and the combined effects of N-and O-glycosylation will be the focus of future studies.
N-Glycosylation enzymes exhibiting a 1.2-fold or greater difference in expression between E12 and E16 NSPCs can be grouped by function (Figure 1 ). N-Acetylglucosaminyltransferases (MGAT3 and MGAT5), along with mannosidase II (MAN2A1 and MAN2A2), determine the degree of N-glycan branching. Sialyltransferases include ST6GAL1, which generates a terminal sialic acid, and ST8SIA2 and ST8SIA4 that work together to form polysialic acid. FUT8 and FUT11 are fucosyltransferases that add fucose residues to the core or terminal ends of N-glycans, respectively. B4GALT2 and B4GALT5 are galactosyltransferases that add galactose to N-glycans. B3GNT2 is an acetylglucosaminyltransferase that adds N-acetylglucosamine (GlcNAc) to N-glycans. The N-glycan branching, sialic acid, and fucose pathways were assessed further to test their association with fate in the neural lineage since multiple members of these pathways were identified in the screen and enzymes that perform different functions were associated with either E12 or E16 NSPCs.
Complex Branching but Not Sialylation or Fucosylation Correlates with NSPC Fate N-Glycan branching is controlled by enzymes that cleave excess mannose residues and initiate new N-glycan branches by attaching GlcNAc (Figure 2A ). High-mannose N-glycans contain no GlcNAc branches, while hybrid N-glycans contain both mannose and GlcNAc, and complex N-glycans have lost all the excess mannose residues. RNA sequencing analysis revealed high expression of N-glycan branching genes, including Man1 isoforms, Man2 isoforms, Mgat1, Mgat2, Mgat3, Mgat4 isoforms, and Mgat5 ( Figure 2B ). NSPCs also express galectins, which bind N-glycans and modulate the activities of several N-glycan-containing cell surface proteins. NSPCs express galectins 1, 4, 5, and 8, but little to no 2, 3, 7, 9, or 12 ( Figure 2B ).
Gene expression analysis by qRT-PCR of Mgat1, the initial N-acetylglucosaminyltransferase in the pathway, and Man2a1, Man2a2, and Mgat5, identified in the initial screen (Figure 1 ), revealed significantly higher levels of Mgat1 in E16 compared with E12 NSPCs ( Figure S1A ). MALDI-TOF mass spectrometry analysis suggested more N-glycans with one or two GlcNAc branches on E12 NSPCs but more with three or four branches on E16 cells ( Figure S1B ). Lectin flow cytometry with fluorescein-conjugated leukocyte-phytohemagglutinin (L-PHA), a plant lectin highly specific for MGAT5-generated highly branched tetra-antennary N-glycans (Cummings and Kornfeld, 1982) , detected higher but not significantly different L-PHA binding on E16 NSPCs compared with E12 cells ( Figure S1C ).
We sorted E12 NSPCs by DEP to generate both control and astrocyte-biased populations Simon et al., 2014) from the same developmental stage since variation between E12 and E16 NSPCs could be due to their different ages independent of fate ( Figure 2C ). We tested enrichment by analyzing undifferentiated cells for markers of astrocyte progenitors (Hartfuss et al., 2001; Sun et al., 2005; Chaboub et al., 2016) and differentiated cells for the formation of GFAP-positive astrocytes. As expected, the astrocyte progenitor markers Asef (Arghgef4), Glast (Slc1a3), and Egfr were more highly expressed in undifferentiated E16 NSPCs than in E12 cells ( Figure S1D ). Expression of astrocyte progenitor markers in undifferentiated cells ( Figure 2D ) and GFAP-positive astrocytes after differentiation ( Figure 2E ) indicate that DEP sorting enriched astrocyte-biased cells. While some NSPCs express GFAP, control and sorted undifferentiated E12 NSPCs do not express GFAP ( Figure S1E ) (Flanagan et al., 2008) , confirming that this marker can be used to detect astrocyte differentiation from these cells. Analysis of both undifferentiated and differentiated cells indicate that sorting generated a more astrocyte-biased population of cells ( Figure 2 ).
We used qRT-PCR to screen for differences in glycosylation enzyme expression between control and sorted astrocyte-biased NSPCs. Sorted cells express significantly higher levels of Man2a1, Man2a2, and Mgat5 and a trend toward higher Mgat1 compared with unsorted E12 NSPCs (Figure 2F) . Notably, sorted cells appear deficient in Mgat3, which prevents formation of highly branched N-glycans (Brockhausen et al., 1988) and was higher in E12 NSPCs than E16 NSPCs in the initial screen (Figures 1 and 2F ). Furthermore, highly branched N-glycans detected by L-PHA were significantly elevated in sorted cells (MFI, 19,423 ± 2,023) compared with unsorted control NSPCs (MFI, 18,101 ± 2,092) (paired Student's t test, p = 0.0157). Together with the analysis of E12 and E16 NSPCs, the sorted cell data indicate a correlation between highly Figure 1 . Differences in N-Glycosylation Enzyme Gene Expression between E12 and E16 Mouse NSPCs Thirty-two N-glycosylation enzyme genes were screened and 12 transcripts differed by more than 1.2-fold; 7 were higher in E16 astrocyte-biased (AB) NSPCs while 5 were higher in E12 neuronbiased (NB) NSPCs. branched N-glycans and the fate of the cell population, suggesting that this pathway may affect membrane capacitance and fate in the neural lineage.
The three enzymes that add sialic acid to N-glycans identified in the original screen of E12 and E16 NSPCs were St6gal1, which had higher expression in E16 NSPCs, and St8sia2 and St8sia4, which were more highly expressed in E12 NSPCs (Figure 1 ). Analysis by qRT-PCR indicated significantly higher levels of St8sia2 and St8sia4 in E12 NSPCs compared with E16 NSPCs, but no difference in St6gal1 ( Figure S2A ). MALDI-TOF studies suggested higher levels of sialic acid containing N-glycans on E12 compared with E16 NSPCs ( Figure S2B ). Using the lectin Sambucus nigra agglutinin (SNA), we found no difference in terminal sialic acid residues generated by ST6GAL1 between E12 and E16 NSPCs ( Figure S2C ). ST8SIA2 and ST8SIA4 form long polysialic acid (PSA) chains, most notably on the neural cell adhesion molecule (NCAM) to generate PSA-NCAM. PSA-NCAM was detected at lower levels on E16 NSPCs compared with E12 cells, but the difference was not significant ( Figure S2D ). Neither St8sia2 expression nor PSA-NCAM differed between the sorted astrocyte-biased population and unsorted NSPCs ( Figures S2E and S2F) . Thus, while there may be more sialic acid on E12 than E16 NSPCs, potentially via the activities of ST8SIA2 and ST8SIA4 but not ST6GAL1, the lack of a difference in St8sia2 and PSA expression in the sorted cells suggests that this may not directly relate to fate. We previously found that isolation of PSA-NCAM-positive cells from E12 NSPCs did not enrich for neuron-generating cells . Furthermore, treatment of blood cells with neuraminidase to remove sialic acid did not change cell responses in DEP frequency ranges that probe the plasma membrane, indicating that the loss of sialic acid did not affect membrane capacitance (Burt et al., 1990) . While E12 NSPCs have higher levels of PSA-generating enzymes than E16 NSPCs, there is not a clear link between PSA and fate-specific membrane capacitance.
Fucosylation of N-glycans occurs through the activities of fucosyltransferases (FUTs). FUT8, which attaches a core fucose, showed the greatest difference in the original screen of E12 and E16 NSPCs and was higher in E16 cells (Figure 1) . Analysis of E12 and E16 NSPCs by qRT-PCR showed slightly higher but not significantly different levels of Fut8 in the E16 sample ( Figure S3A ), and core-fucosylated N-glycans were slightly elevated in E16 NSPC membranes compared with those from E12 as indicated by MALDI-TOF (Figure S3B) . However, lectin flow cytometry with Lens culinaris agglutinin, which detects core-fucosylated N-glycans, indicated similar levels of core fucose on E16 NSPCs and E12 NSPCs ( Figure S3C ). In addition, Fut8 expression did not differ between the unsorted control NSPCs and the sorted astrocyte-biased population ( Figure S3D) . Thus, the analysis of Fut8 expression and activity in NSPCs did not provide evidence of a significant association between core fucosylation and fate in the neural lineage.
Highly Branched N-Glycans Increase in the Brain Stem Cell Niche as Fate Shifts from Neurogenesis to Astrogenesis Development of the mammalian cerebral cortex proceeds in a stepwise pattern with neurons formed first (E10 in mice) followed by astrocytes (E16). The sequential generation of neurons and astrocytes provides a means to test the association of glycosylation with fate in vivo. Cortical NSPCs reside in the ventricular zone/subventricular zone (VZ/SVZ) of the embryonic cerebral cortex, and differentiated cells migrate away from this region toward the pial surface to form the cortical plate (CP). We analyzed sagittal brain sections from E10-E18 embryos and used the NSPC markers Sry-box (SOX) 1 and SOX2 to mark the VZ/SVZ and microtubule-associated protein 2 (MAP2) and doublecortin (DCX) as markers of differentiated neurons to define the CP ( Figure S4 ). Oligodendrocytes are not primarily generated in the cortex; most form ventrally in the ganglionic eminence and migrate to inhabit the cortex (dorsal telencephalon) at later embryonic stages, E18 (He et al., 2001 ). Thus, very few oligodendrocyte progenitors would be present in the cortical stem cell niche.
We used L-PHA lectin staining to assess highly branched N-glycans in the VZ/SVZ stem cell niche and found significantly more L-PHA binding at E16 than at E12 (Figure 3 ). There was no difference in staining of the CP at E12 and E16, showing that the differences in the VZ/SVZ were not due to general increases in highly branched N-glycans in all regions of the cortex over time. The levels of highly branched N-glycans continue to increase in the VZ/SVZ NSPC niche at E18 as astrogenesis escalates ( Figures 3C,  3D , and S5). Together with the results from cell culture studies, these data show that highly branched N-glycans are associated with astrogenic NSPC populations both in vitro and in vivo.
GlcNAc Treatment Enhances Expression of Highly Branched N-Glycans on E12 NSPCs and Significantly Increases Membrane Capacitance
We tested whether altering highly branched N-glycans on the surface of E12 NSPCs changes their membrane capacitance values by supplementing the cells with GlcNAc, which is readily taken up by cells and raises intracellular UDP-GlcNAc levels. The MGAT4 and MGAT5 branching enzymes are highly sensitive to availability of UDP-GlcNAc, and GlcNAc treatment increases N-glycan branching in a variety of cell types (Lau et al., 2007) . GlcNAc treatment significantly increased highly branched N-glycans detected by L-PHA on the surface of E12 NSPCs (Figure 4) . Increasing cell surface highly branched N-glycans also caused a significant increase in whole-cell membrane capacitance of E12 NSPCs, indicating a role for branched N-glycans in membrane capacitance ( Figure 4C ). Error bars SEM. N = 3 or more independent biological repeats (**p < 0.01, ***p < 0.001, ****p < 0.0001).
2008).
We assessed neuronal differentiation of control and GlcNAc-treated E12 NSPCs to test whether highly branched N-glycans impact fate. GlcNAc treatment led to a dose-dependent decrease in neuron formation, with significantly lower neurogenesis after treatment with 40 or 80 mM GlcNAc ( Figures 5A and 5B ). There was no difference in cell size of control and 80 mM GlcNAc-treated NSPCs ( Figure 5C ), consistent with the fact that neither NSPCs that differ in fate (E12 and E16) nor astrocyte-and neuron-biased populations enriched from E12 NSPCs differ in size (Labeed et al., 2011; Nourse et al., 2014) . GlcNAc supplementation might induce cell death, leading to the loss of cells biased to a particular fate. Yet there was no difference in cell viability or percentage of apoptotic cells between control and GlcNAc-treated NSPCs, suggesting that cell death does not play a role in the effect of highly branched N-glycans on fate ( Figure 5D ). Highly branched N-glycans could alter cell proliferation, impacting the percentage of neuron-biased cells in the population. However, two measures of cell proliferation (EdU incorporation and phosphorylated histone H3 expression) showed no differences between control and GlcNAc-treated NSPCs (Figure 5E ). In sum, GlcNAc treatment to induce highly branched N-glycans on E12 NSPCs decreases neurogenesis but not by altering cell size, viability, or proliferation.
Enhancing Highly Branched N-Glycans on Undifferentiated NSPCs Leads to the Formation of More Astrocytes at the Expense of Neurons
GlcNAc treatment effects could be due to branched N-glycans on undifferentiated NSPCs, on newly differentiated cells, or a combination of both since GlcNAc treatment spanned proliferation and differentiation stages ( Figure 5 ). Experiments were therefore designed to separate these effects by treating cells (1) when in the undifferentiated state (in proliferation medium), (2) as they differentiate (in differentiation medium), or (3) during both stages (throughout) ( Figure 6A ).
GlcNAc treatment throughout both proliferation and differentiation stages led to a significant decrease in neuron formation ( Figures 6B and 6D , ''throughout'') as seen in our initial experiments of neuron differentiation ( Figure 5 ). Treatment during only the proliferation stage induced a similar decrease in neuron formation, but treatment during the differentiation stage had no effect on the percentage of neurons ( Figures 6B and 6D , ''proliferation,'' ''differentiation''). These data indicate that increasing cell surface highly branched N-glycans decreases the neurogenic potential of undifferentiated E12 NSPCs rather than affecting differentiated neurons.
Analysis of astrocyte generation from E12 NSPCs treated with GlcNAc revealed effects of highly branched N-glycans on both undifferentiated and differentiated cells. Astrocyte quantitation was standardized by analyzing regions that did not contain dense clusters of cells and cell debris (Figure S6 ) since astrocytes can become reactive in response to dying cells and upregulate GFAP expression, complicating analysis. GlcNAc treatment of undifferentiated NSPCs led to a significant increase in the percentage of astrocytes formed after differentiation ( Figures 6C and 6E , proliferation). Interestingly, treatment during the differentiation stage also significantly increased astrocyte percentages, suggesting effects of highly branched N-glycans on the differentiated cells ( Figures 6C and 6E, differentiation) . The percentage of astrocytes formed when GlcNAc treatment occurred throughout both proliferation and differentiation stages was significantly higher than that of cells treated just during proliferation, suggesting an additive effect on both undifferentiated and differentiated cells ( Figures 6C and 6E, throughout) . Thus, highly branched N-glycans impact the formation of astrocytes from NSPCs and also affect differentiated astrocytes.
At E12, cortical NSPCs primarily generate neurons and astrocytes, and the number of cells in the cortex capable of making oligodendrocytes is low, in part since very few oligodendrocyte-producing cells have migrated from the ganglionic eminence into the cortex at this stage (He et al., 2001 ). However, since E12 cortical NSPCs can generate low numbers of oligodendrocytes in culture (Qian et al., 2000) , we assessed the effects of GlcNAc on oligodendrocyte generation. Oligodendrocyte percentages were significantly decreased when cells were treated with 80 mM GlcNAc during proliferation or throughout both proliferation and differentiation stages, but not when treated during differentiation only ( Figure S7 ). Since E12 NSPCs generate few oligodendrocytes, the biological (legend continued on next page) significance of this finding is unclear, and further analysis should utilize cells isolated from the ganglionic eminence or other means to assess cells capable of generating higher numbers of oligodendrocytes.
GlcNAc is utilized in both N-and O-glycosylation, so we tested whether GlcNAc effects were specifically due to incorporation in N-glycan branching by pretreating cells with kifunensine (Kif). Kif is a highly specific inhibitor of mannosidase I and blocks the first steps of N-glycan branching (Figure 2A ) (Males et al., 2017) . E12 NSPCs were pre-treated with Kif and maintained in Kif during GlcNAc treatment to prevent GlcNAc incorporation into N-glycan branches ( Figure 7A ). As indicated by L-PHA flow cytometry, Kif effectively blocked branching since no increase in branched N-glycans occurred with GlcNAc in the presence of Kif ( Figure 7B ). No significant difference in neuron formation was observed between Kif-treated NSPCs and cells treated with both Kif and GlcNAc, indicating that Kif blocked the effect of GlcNAc on NSPC neurogenesis ( Figure 7C ). Similarly, Kif prevented the effect of GlcNAc on astrogenesis since the Kif-treated NSPCs did not differ from those treated with both Kif and GlcNAc (Figure 7D) . The ability of Kif to block the effects of GlcNAc indicates that GlcNAc influences the fate potential of NSPCs through the formation of branched N-glycans.
DISCUSSION
We identify the N-glycosylation pathway leading to the formation of highly branched N-glycans as a regulator of fate choice in the neural lineage and provide links between the expression of N-glycans on the cell surface and membrane capacitance, a novel label-free biomarker of cell fate. Neurogenic and astrogenic NSPCs differ in expression of enzymes that lead to the formation of highly branched N-glycans, and these N-glycans increase in the stem cell niche in vivo as fate potential shifts from neurogenesis to astrogenesis. NSPCs induced to express more highly branched N-glycans had significantly increased fate-specific membrane capacitance values, providing a direct link between cell surface glycosylation and this biophysical property. Increasing the levels of NSPC highly branched N-glycans specifically affected fate choice since GlcNAc treatment led to the formation of greater percentages of astrocytes at the expense of neurons without affecting cell size, proliferation, or death. These data indicate that the N-glycan branching pathway is an important regulator of fate choice in the neural lineage.
Cell surface N-glycosylation significantly impacts membrane capacitance, a label-free measure of cell fate. Glycosylation likely affects capacitance values of many cell types since reductions in the complexity of the bacteria C. difficile S-layer, which is made up of glycoproteins and glycans on the bacterial envelope, induces shifts in membrane capacitance (Su et al., 2014) . Glycosylation may contribute to membrane capacitance in other stem cell lineages; differentiation of MSCs to either adipogenic or osteogenic fates is associated with differences in both membrane capacitance (Bagnaninchi and Drummond, 2011) and glycosylation (Heiskanen et al., 2009; Hamouda et al., 2013) . The interaction of membrane capacitance, cell fate, and cell surface glycosylation may have relevance for many cell types, including those in other stem cell lineages.
Cell surface glycosylation affects membrane structure and surface area, which are expected to impact whole-cell membrane capacitance (Wang et al., 1994) . The size of neuron-and astrocyte-biased NSPCs enriched by DEP did not differ and there was no difference in the size of untreated and GlcNAc-treated NSPCs in phase contrast microscopy although they differ in both membrane capacitance and fate (e.g., Figures 4, 5, and 6) . Cell surface glycosylation affects the formation of membrane microdomains such as microvilli and lipid rafts associated with membrane invaginations, and thus could lead to changes in surface area not visible by phase contrast (Zhao et al., 2002; Garner and Baum, 2008) . The cell surface glycocalyx (glycoproteins, glycolipids, and galectins) can create thickened regions of membrane that may affect capacitance (Paszek et al., 2014) . The shift in membrane capacitance of E12 NSPCs due to GlcNAc treatment (untreated: 8.2 ± 0.2 mF/m 2 ; GlcNAc 10.7 ± 0.6 mF/m 2 ) (Labeed et al., 2011) . Thus, cell surface highly branched N-glycans could be sufficient to explain the fate-specific differences in capacitance of NSPCs. Increasing highly branched N-glycans on NSPCs alters fate potential, leading to the generation of more astrocytes and fewer neurons while not inducing changes in cell proliferation or viability. A direct role for branched N-glycans in NSPC differentiation has not been previously described, although glycosylation patterns shift in the cortex during developmental stages of increased neuron or astrocyte production (Ishii et al., 2007) . Deletion of the N-glycan branching enzyme MGAT1 results in failed neural tube closure and embryonic lethality (Ioffe and Stanley, 1994) . Loss of MGAT2 critical for the formation of branched N-glycans causes congenital disease with mental and psychomotor retardation (Schachter, 2001) . The role of branched N-glycans in NSPC differentiation warrants further study. The effects of highly branched N-glycans on NSPCs could relate to N-glycan interactions with galectins. Galectin affinity is proportional to the number of sugar residues available for binding, and so is increased when glycans are more branched and elongated from each branchpoint with N-acetyllactosamine (Lau et al., 2007; Nabi et al., 2015) . Galectins may influence NSPC differentiation since NSPCs make galectin 1 (Figure 2) , which induces astrocyte maturation in vitro (Sasaki et al., 2004) and downregulates neurogenesis in the adult rodent hippocampus (Imaizumi et al., 2011) . Interaction of galectin 1 with the highly branched N-glycans induced by GlcNAc may be part of the process leading to more astrocytes but fewer neurons from GlcNAc-treated E12 NSPCs.
N-linked glycosylation regulates multiple receptor classes and is thus well poised to affect cell differentiation. (D) When blocked by Kif, GlcNAc has no effect on astrocyte formation since no difference was observed between Kif-and Combo-treated samples. Error bars SEM. N = 3 or more independent biological repeats (*p < 0.05, ****p < 0.0001).
N-Glycan content governs plasma membrane receptor cell surface residence time and ligand affinity, affecting integrins that bind ECM (b1, a3, a5, and aV), cell-cell adhesion proteins (cadherins), and receptors for growth factors and morphogens (e.g., EGFR, PDGFR, gp130 subunit of CNTFR) (Pinho and Reis, 2015) . The loss of MGAT5 and branching reduces cell responses to EGF, PDGF, bFGF, and IGF (Partridge et al., 2004) . N-Glycan branching governs cell proliferation through the regulation of growth-promoting (e.g., EGFR and PDGFR) and growth arrest receptors (e.g., TGF-bR) that differ in numbers of N-glycan sites (Lau et al., 2007) . Thus, differences in the cell surface glycosylation of neuron-and astrocyte-biased NSPCs may not only contribute to their distinct membrane capacitance values but also specifically regulate multiple types of receptors that guide fate.
Our data suggest that MGAT5 may be more active in cells that will form astrocytes and MGAT3 in neuronbiased NSPCs, raising the possibility that the balance of these enzymes affects fate decisions. MGAT3 antagonizes the activity of MGAT5 since the formation of a bisecting N-glycan by MGAT3 prevents further branching by MGAT5 (Brockhausen et al., 1988) . The Mgat5 gene is more highly expressed in astrogenic-biased NSPCs (E16 and DEP enriched), while the levels of Mgat3 are higher in more neurogenic NSPC populations (E12 and unsorted) (Figures 1 and 2 ). GlcNAc treatment increases highly branched N-glycans formed by MGAT5, leading to greater astrogenesis and reduced neurogenesis (Figures 5 and 6 ). Pluripotent stem cells that differentiate into neurons upregulate MGAT3 expression and have higher cell surface bisecting N-glycans, whereas differentiated astrocytes retain low levels of bisecting N-glycans (Terashima et al., 2014) . The balance of MGAT3 and MGAT5 activity regulates several proteins impacting cell function. Overexpression of MGAT5 or loss of MGAT3 induces greater integrin-mediated migration, while high levels of MGAT3 cause reduced migration (Zhao et al., 2006) . The generation of more bisecting N-glycans on cadherins fosters greater cell-cell adhesion, whereas more highly branched N-glycans decrease cellcell adhesion (Guo et al., 2003; Pinho et al., 2009 ). The degree of MGAT3 and MGAT5-modified N-glycans on the cell surface of NSPCs could regulate responses to a variety of extracellular cues and thus alter fate potential.
EXPERIMENTAL PROCEDURES
NSPC Cell Culture and GlcNAc Treatment
All studies were approved by the Institutional Animal Care and Use Committee at UCI. Mouse E12 or E16 NSPCs were isolated from the cerebral cortex, grown and differentiated as previously described . GlcNAc (Fisher Scientific) was prepared as a stock solution in medium and supplemented in medium daily. Full details for all experimental procedures are provided in Supplemental Experimental Procedures.
Immunocytochemistry and Fate Potential Analysis
NSPCs were fixed and stained with antibodies as described previously . Cells double-positive for MAP2/ DCX or MAP2/TUJ1 with neurites at least three times the length of the soma were counted as neurons. Cells expressing GFAP in a filamentous cytoskeletal pattern were counted as astrocytes.
RNA Isolation, RNA Sequencing, and Analysis RNA was isolated from E12 NSPCs, E16 NSPCs, or E12 cerebral cortex as a control, and cDNA synthesized using M-MLV reverse transcriptase. cDNA was analyzed using the RT 2 Profiler PCR Array (QIAGEN) for 84 mouse glycosylation-related genes or qRT-PCR with primers for specific glycosylation enzymes.
Lectin Flow Cytometry
Live NSPCs were labeled with lectins (e.g., 20 mg/mL FITC-conjugated L-PHA) (Vector Labs) and propidium iodide was used to exclude non-viable cells for analysis.
DEP-Based NSPC Sorting and Capacitance Measurements
Mouse NSPCs were sorted using DEP devices and sorting parameters as described previously, ensuring DEP had no effect on NSPC survival, proliferation, or differentiation potential Simon et al., 2014) . Dissociated cells (3 3 10 6 cells/mL)
were placed in DEP wells, electrodes were actuated at 100 kHz, 3 Vpp for 5 min or less, and cells attracted to the electrodes were collected. Membrane capacitance measurements used the DEPWell system (Labeed et al., 2011) .
Brain Tissue Section Analysis
CD-1 mice brains were collected at E10, E12, E16, and E18, and sagittal sections (20 mm) stained with antibodies or lectins. Quantitative analysis used ImageJ to calculate signal intensity in at least ten randomly selected areas within each layer (lectin-stained blood vessels were excluded). Minimum intensity values were subtracted from maximum values to control for variation in staining across samples.
Statistical Analysis
Statistical analysis used Prism v.6 software (GraphPad). Comparison of two samples utilized two-tailed unpaired Student's t tests except for qRT-PCR data obtained from E12 NSPCs and sorted cells, which were analyzed by a paired t test since the same sample was measured before and after sorting. Datasets containing more than two samples were analyzed by one-way ANOVA. A Dunnett's post hoc correction was applied for the GlcNAc dose-response experiments to compare all GlcNAc treatment groups with the untreated control, and a Tukey's post hoc correction was applied for all other multiple comparisons. 
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